Showing results (661-670 of 6,880) with videos related to
Sort By:
Pageof 688
Leukemia Research|March 9, 2012
Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular responseHo-Young Yhim, Na-Ri Lee, Eun-Kee Song, et al.Leukemia Research|March 6, 2012
Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium studySusan Bell Nyland, Daniel J Krissinger, Michael J Clemente, et al.Leukemia Research|March 6, 2012
Could age modify the effect of genetic variants in IL6 and TNF-α genes in multiple myeloma?Alessandro Martino, Gabriele Buda, Valentina Maggini, et al.Leukemia Research|January 1, 1990
Control of actin conformation in AML myeloblasts: the effects of bryostatin and TPAR L Sham, C H Packman, C N Abboud, et al.Leukemia Research|January 1, 1990
Lithium enhances the proliferation of HL-60 promyelocytic leukemia cellsR W Becker, E M TyobekaLeukemia Research|January 1, 1990
Therapy of acute myelogenous leukemia in patients over the age of 50: a randomized Southeastern Cancer Study Group trialR S Stein, W R Vogler, E F Winton, et al.Leukemia Research|January 1, 1990
Elevated argininosuccinate synthetase activity in adult T leukemia cell linesK Sugimura, T Kimura, H Arakawa, et al.Leukemia Research|May 30, 2012
Impairment in differentiation and cell cycle of thymocytes by loss of a Bcl11b tumor suppressor allele that contributes to leukemogenesisRieka Go, Kazuyoshi Takizawa, Satoshi Hirose, et al.Leukemia Research|December 17, 2009
In vitro basis for treatment with hypomethylating agents and histone deacetylase inhibitors: can epigenetic changes be used to monitor treatment?Steven D GoreLeukemia Research|January 1, 1986
Transferrin induces maturation of neutrophil granulocyte precursors in vitroW H Evans, S M Wilson, M G MagePageof 688